𝔖 Bobbio Scriptorium

✦ LIBER ✦

Outcome evaluation or treatment research?: A response to Ciarlo (1982)

✍ Scribed by William A. Hargreaves

Book ID: 119081372
Publisher: Elsevier Science
Year: 1982
Tongue: English
Weight: 252 KB
Volume: 5
Category: Article
ISSN: 0149-7189
DOI: 10.1016/0149-7189(82)90008-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcome assessment in evaluation and tre

Outcome assessment in evaluation and treatment research: A response to Ciarlo and Hargreaves (1982)

✍ Frederick L. Newman 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 380 KB

18F-Fluorodeoxyglucose positron emission

18F-Fluorodeoxyglucose positron emission tomography in evaluating treatment response to imatinib or other drugs in gastrointestinal stromal tumors: a systematic review

✍ Giorgio Treglia; Paoletta Mirk; Antonella Stefanelli; Vittoria Rufini; Alessandr 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 313 KB

Clinical trial patients’ topical treatme

Clinical trial patients’ topical treatment medication adherence: poor adherence or over adherence to a clinical trial regimen can adversely affect the validity of research outcomes.

✍ Sameh S. Zaghloul; Mark Goodfield 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 59 KB

A systematic review of the role of mutan

A systematic review of the role of mutant p53 in predicting outcome or response to treatment in head and neck squamous cell carcinoma (HNSCC). : Abstracts of the Otorhinolaryngological Research Society Meeting Autumn Meeting 26th September 2008, UCL Ear Institute, Gray's Inn Road, London

✍ S. Tandon; C. Tudur-Smith; S. Ghosh; M. Boyd; T.M. Jones 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB

Long-Term Clinical Outcome Based on Aspi

Long-Term Clinical Outcome Based on Aspirin and Clopidogrel Responsiveness Status After Elective Percutaneous Coronary Intervention: A 3T/2R (Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel) Trial Substudy

✍ Gianluca Campo; Luca Fileti; Nicoletta de Cesare; Emanuele Meliga; Alessandro Fu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 1020 KB

A phase II randomized, double-blind, pla

A phase II randomized, double-blind, placebo-controlled multicenter study of recombinant human interleukin-12 for the treatment of chronic hepatitis C virus infection in patients non-responsive to previous treatment with interferon-alpha with or without ribavirin: Paul J Pockros, John G McHutchison, Scripps Clinic, La Jolla, CA; Chris O'Brien, University of Miami, Miami, FL; Myron Tong, Huntingon Medical Research Institute, Pasadena, CA; Coleman Smith, Minnesota Clinical Research Center, St. Paul, MN; Vinod Rustgi, Metropolitan Research Group, Fairfax, VA; Robert L Carithers, University of Washington Medical Center, Seattle, WA; Elizabeth Olek, Genetics Institute, Cambridge, MA

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB